ALXN - Alexion Pharmaceuticals' (ALXN) CEO Ludwig Hantson on Q3 2020 Results - Earnings Call Transcript

Alexion Pharmaceuticals, Inc. (ALXN) Q3 2020 Earnings Conference Call October 29, 2020 8:00 AM ET Company Participants Chris Stevo – Head-Investor Relations Ludwig Hantson – Chief Executive Officer Aradhana Sarin – Chief Financial Officer John Orloff – Global Head-R&D Brian Goff – Chief Commercial and Global Operations Officer Conference Call Participants Josh Schimmer – Evercore ISI Cory Kasimov – JPMorgan Geoffrey Porges – SVB Leerink Chris Raymond – Piper Sandler Phil Nadeau – Cowen and Company Mohit Bansal – Citigroup Geoff Meacham – Bank of America Presentation Operator Ladies and gentlemen, thank you for standing by, and welcome to Alexion Pharmaceuticals Third Quarter 2020 Results Conference Call. [Operator Instructions] Please be advised that today’s conference may be recorded. I’d now like to hand the conference over to your host today, Mr. Chris Stevo, Head of Investor Relations. Please go ahead. Chris Stevo Thank you, operator. Good morning. Thank you for

For further details see:

Alexion Pharmaceuticals' (ALXN) CEO Ludwig Hantson on Q3 2020 Results - Earnings Call Transcript